Resveratrol targeting tau proteins, amyloid-beta aggregations, and their adverse effects: An updated review.

Ashrafizadeh, Milad; Zarrabi, Ali; Najafi, Masoud; Samarghandian, Saeed; Mohammadinejad, Reza; Ahn, Kwang Seok

Ashrafizadeh, Milad; Zarrabi, Ali; Najafi, Masoud; Samarghandian, Saeed; Mohammadinejad, Reza; Ahn, Kwang Seok.

Afiliação

Ashrafizadeh M; Department of Basic Science, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.
Zarrabi A; Sabanci University Nanotechnology Research and Application Center (SUNUM), Tuzla, Turkey.
Najafi M; Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Samarghandian S; Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran.
Mohammadinejad R; Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Ahn KS; College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.

Phytother Res ; 34(11): 2867-2888, 2020 Nov.

Article em En | MEDLINE | ID: mdl-32491273

Assuntos

Peptídeos beta-Amiloides/efeitos dos fármacos; Resveratrol/uso terapêutico; Proteínas tau/efeitos dos fármacos; Humanos; Resveratrol/farmacologia

Palavras-chave

aggregation; amyloid-beta; neurological disorders; neuroprotective; resveratrol; tau protein

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos beta-Amiloides / Proteínas tau / Resveratrol Idioma: En Revista: Phytother Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google